These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2248078)

  • 21. Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
    Delini-Stula A; Mikkelsen H; Angst J
    J Affect Disord; 1995 Oct; 35(1-2):21-30. PubMed ID: 8557884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moclobemide (Ro 11-1163) in long-term treatment.
    Stefanis CN; Merz-Frei K
    Acta Psychiatr Scand Suppl; 1990; 360():67-8. PubMed ID: 2123368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of the pressor effect of intravenously administered tyramine during moclobemide treatment.
    Zimmer R; Fischbach R; Breuel HP
    Acta Psychiatr Scand Suppl; 1990; 360():76-7. PubMed ID: 2248082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients.
    Hawley CJ; Quick SJ; Ratnam S; Pattinson HA; McPhee S
    Int Clin Psychopharmacol; 1996 Sep; 11(3):187-91. PubMed ID: 8923097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
    Larsen JK; Holm P; Mikkelsen PL
    Acta Psychiatr Scand; 1984 Sep; 70(3):254-60. PubMed ID: 6388247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Casacchia M; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
    J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Moclobemide].
    Gleiter C; Volz HP
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1175-6. PubMed ID: 7656852
    [No Abstract]   [Full Text] [Related]  

  • 30. Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness.
    Fitton A; Faulds D; Goa KL
    Drugs; 1992 Apr; 43(4):561-96. PubMed ID: 1377119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind comparative trial of moclobemide v. imipramine and placebo in major depressive episodes.
    Versiani M; Oggero U; Alterwain P; Capponi R; Dajas F; Heinze-Martin G; Marquez CA; Poleo MA; Rivero-Almanzor LE; Rossel L
    Br J Psychiatry Suppl; 1989 Oct; (6):72-7. PubMed ID: 2695129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M; Guelfi JD
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin syndrome--clomipramine too soon after moclobemide?
    Gillman PK
    Int Clin Psychopharmacol; 1997 Nov; 12(6):339-42. PubMed ID: 9547136
    [No Abstract]   [Full Text] [Related]  

  • 34. Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
    König F; Wolfersdorf M; Löble M; Wössner S; Hauger B
    Pharmacopsychiatry; 1997 Jul; 30(4):125-7. PubMed ID: 9271778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
    Versiani M; Amrein R; Stabl M
    Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
    Zimmer R
    Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
    Becker T; Struck M; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multicenter study comparing efficacy and tolerance of moclobemide and fluvoxamine in hospitalized and ambulatory patients with severe depressive episodes].
    Barrelet L; Blajev B; Bolzani L; de Saussure C; Kasas A; Van H; Gachoud JP
    Schweiz Rundsch Med Prax; 1991 May; 80(19):524-8. PubMed ID: 1904620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moclobemide compared with second-generation antidepressants in elderly people.
    De Vanna M; Kummer J; Agnoli A; Gentili P; Lorizio A; Anand R
    Acta Psychiatr Scand Suppl; 1990; 360():64-6. PubMed ID: 2248077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment with selective and reversible monoamine oxidase inhibitors in depressed patients: is there a biological effect proportional to the dose?].
    Radat F; Berlin I; Varoquaux O; Ferreri M; Puech A
    Ann Med Psychol (Paris); 1996 Jun; 154(3):204-6. PubMed ID: 8766502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.